In what Guggenheim Partners called one of Metsera’s “critical program milestones” this year, its ultra-long-acting amylin ...

The Fund (Institutional Class) returned 0.29 percent (0.47 percent gross) for the first quarter of 2025 compared to the S&P ...

Shares of Ardent Health Partners, LLC (NYSE:ARDT – Get Free Report) have received an average rating of “Buy” from the ...

Friedman reported significant international momentum, citing RH England's gallery up 47% in demand and online demand at 44% for the quarter. He stated, "Current demand trends indicate the gallery will ...

The Louisiana Museum of Modern Art is staging the first comprehensive survey of late artist Kaari Upson’s work ...

Pavel Kolesnikov and Samson Tsoy are transforming the classical scene with their transcendent piano performances ...

Triclonics ®  and ADClonics ® ), today announced the pricing of an underwritten public offering of 5,263,158 common shares, at a public offering price of $57.00 per share (the “Offer Shares”). Merus ...

ADC Therapeutics SA , a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that it has entered into securities purchase agreements for the sale ...